News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here's Why Amazon, Apple, and Tesla Investors Should Pay Attention.2Exxon’s Guyana-Permian Engine Fuels 21% Earnings Growth—Is the 24 P/E Already Discounting a Squeeze?3Bitcoin’s Movement Compared to Oil’s Rally: Evaluating a Risk-Off Scenario
REDNEW fluctuated 121.2% in 24 hours: Amplified by low-liquidity DEX trading, no clear catalyst
Bitget Pulse·2026/04/06 22:00
Talon Metals Gains Momentum from Nickel Buzz—Yet Outstanding Warrants May Limit Further Upside
101 finance·2026/04/06 21:54
Myseum’s complimentary wedding QR trial may ignite widespread use of privacy-focused corporate social engagement
101 finance·2026/04/06 21:54
FuelCell Energy's Cash Cushion Masks a Widening Execution Gap as Contract Revenue Crumbles
101 finance·2026/04/06 21:54
Soulpower’s Empty Board Seat Creates Underlying Tension Before Crucial Merger Submission
101 finance·2026/04/06 21:51
SEC crypto safe harbor heads to White House review, proposal due 'shortly' says Atkins
The Block·2026/04/06 21:48
GLBE: Major Insider Sells as Institutional Giant Buys — Contrasting Moves Among Savvy Investors
101 finance·2026/04/06 21:45
Flash
21:46
Regenerative medicine giant Organogenesis Holdings Inc (ORGO) recently announced the successful completion of a key meeting with the U.S. Food and Drug Administration (FDA).The two parties reached a consensus on the clinical development pathway of Renu® regenerative cell technology for the treatment of knee osteoarthritis pain. The company clearly stated that it will accelerate the regulatory submission process based on the meeting's guidance and plans to officially submit a Biologics License Application (BLA). This innovative therapy aims to target and repair knee cartilage tissue through a cell regeneration mechanism, providing a new non-surgical intervention option for hundreds of millions of osteoarthritis patients worldwide. This milestone event marks a significant breakthrough in the commercialization process of the Renu® product. Industry analysts pointed out that if approved for market launch, this product could reshape the market landscape of the orthopedic pain treatment sector. Influenced by this positive news, the company’s stock price showed an upward trend in after-hours trading.
21:42
(PAC) Fairshake: Holds $193 million in campaign funds ahead of the November 2026 midterm electionsJinse Finance reported that on April 7, the cryptocurrency-backed political action committee (PAC) Fairshake stated it had spent over $130 million on media buying for the 2024 election. The committee said in January that it has $193 million in campaign funds available through the November 2026 midterm elections. The organization is not the only group supporting cryptocurrency nationwide. Fellowship PAC claims to have raised "over $100 million" from undisclosed backers closely linked with the cryptocurrency industry, and on Wednesday, announced the appointment of Tether executive Jesse Spiro as chairperson.
21:24
Bitcoin's 30-day average transaction fee drops to the lowest level since 2011The 30-day average transaction fee for Bitcoin has dropped to 2.5 BTC per day, the lowest level since 2011, indicating weak on-chain demand. (Cointelegraph)
News